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Abstract. Developing software for the manufacture of medical devices is a 
sensitive operation from many perspectives, such as: safety and regulatory 
compliance. Medical Device companies are required to have a well defined 
development process in place, which includes software development, and be 
able to demonstrate that they have followed it through the complete life-cycle of 
the device. With the increasing complexity of Medical Devices, and more 
detailed software development regulations among some of the influencing 
factors, we take a look at how some of these factors have impacted the software 
development process within a medical device manufacturing plant. We find that 
tying down your process across the board can have unwanted consequences. As 
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1   Introduction 
 
As would be expected, the concern for human safety takes precedence when it comes 
to the development of a Medical Device (MD). To ensure the lowest level of risk to 
safety, various regulatory controls have been established governing the development 
process. For example within the European Union, the Medical Device Directive [1], 
[2] define a set of harmonised rules relating to the safety and performance of MDs. 
One particular aspect which has gained increased attention from a regulatory 
perspective is the software development life-cycle (SDLC). The software component 
of a MD is playing an increasingly important role in the construction and operation of 
MDs, and is becoming more and more complex. This has been reflected in the 
relatively recent addition to the definition of a MD, for example by the U.S. Food and 
Drugs Administration (FDA) [3], to include software in its own right as a possible 
MD. 
One thing which is worth noting is that MD software covers embedded-software 
and also software involved in the manufacturing of the device. It is within this context 
that we examine the software development process of an Irish based MD 
manufacturing plant to see how they configure their internal processes, and what the 
influencing factors are in achieving regulatory compliance. 
 
1.1   Software for the Medical Device Industry 
 
Medical devices can be defined as being safety-critical. Other domains which fall into 
this category are the Aviation, Automobile, Railway, and Nuclear among others. As 
mentioned above, the obvious concern is around safety, and the aim is to minimise the 
risk of injury to humans to an acceptable level. Each of these safety-critical domains 
has developed and published standards and guidelines to help achieve the safest 
possible end-product. For example: the DO-178B guidelines for airborne systems and 
equipment [4], and the U.S. code of federal regulations title 21 part 820 governing the 
quality system regulations for medical device manufacturers [5].  
Since software is increasingly becoming an integral part of a MD, we have seen an 
increase in the number of injuries caused to patients which have been directly 
attributed to the software component. FDA analysis of 3,140 medical device recalls 
between 1992 and 1998 found that 242 (over 7%) were attributable to software [6]. 
Significantly, of the recalls in 2007 of what the FDA classify as life-threatening, 23 of 
them involved faulty software [7]. As a consequence, regulatory controls are 
continuously being reviewed and adapted to this ever advancing technological 
landscape. In 2006 an international standard (ANSI/AAMI/IEC 62304:2006) was 
published which governs the MD SDLC processes [8]. Now widely adopted, IEC 
62304 establishes a common framework for medical device life-cycle process by 
describing a set of processes, activities, and tasks that are required within a MD 
SDLC. 
However, reading the standards can lead to thinking that a waterfall-type software 
development methodology is what will best meet the requirements. This is in fact not 
the case, and Annex B of the IEC 62304 standard specifically clarifies that: ―This 
standard does not require a particular SOFTWARE DEVELOPMENT LIFE CYCLE 
MODEL‖. This allows companies to employ whatever methodology they prefer, for 
example, Incremental or Evolutionary. Typically MD companies employ a traditional 
SDLC model (waterfall or V), but lately, more focus is being given to examining how 
these companies can improve their SDLC processes, for example by employing a 
more iterative development  methodology [9], [10]. 
  
1.2   Lean Software Development 
 
The concept of Lean Software Development can be thought of as the merging of the 
principles of Lean Manufacturing [11], [12], with software development practices. 
Lean‘s primary focus is on the identification and elimination of waste from the 
process. Waste being defined as ―any human activity which absorbs resources but 
creates no value‖ [13]. So lean thinking ―is lean because it provides a way to do more 
and more with less and less – less human effort, less equipment, less time, and less 
space – while coming closer and closer to providing customers with exactly what they 
want‖ [13].  
Eliminating waste, when translated into software engineering terms, can mean the 
elimination of defects (bugs) in the code. This may seem an obvious goal of 
developing software, but the creation of formal mechanisms to achieve this began to 
show the power of doing this in a systematic fashion. This is one of the cornerstones 
of what Lean Software Development is founded on, finding and fixing defects early in 
the development process. Many of the Agile software development practices [14], 
[15] can be seen as supportive of a lean philosophy (Fig. 1). For example, the agile 
practice of test driven development (TDD) [16] in order to find defects early by 
continuous testing and thus reducing the cost of rework later. Many more such 
practices have been mapped by [17] and [18]. 
 
 
Fig. 1. Lean Software Development 
 
Of interest therefore is how such ‗lean practices‘ can be utilised in the MD 
domain, something the industry is also looking at [10]. With a focus on an iterative 
approach to software delivery, and favouring less rather than more documentation 
[19], companies can shy away from such practices out of fear of a costly non-
compliance outcome. Slowly, however, we are seeing more and more reports from 
companies who are trialling lean approaches in this domain [20], [21], [9]. 
 
 
2   Research Approach 
 
Following on from a systematic literature review of software development within 
safety-critical regulated environments [22], we were interested in investigating further 
how the various regulations and other influencing factors affect the software 
development process within the MD domain, and how a lean perspective could be 
beneficial. Our approach to this was to undertake a case study within a MD company, 
using [23], [24] as guides. Taking an interpretative approach, we requested one-to-one 
interviews with a cross section of the organisation involved in projects which had a 
software development component. Eight onsite interviews were performed lasting 
between sixty and ninety minutes each. The interviewees all had relevant firsthand 
experience of the complete product development process and the governing policies 
and procedures. They included senior software developers, a senior quality engineer, 
a process engineer, and project leaders. Their work experience ranged from 7 to 18 
years, and from 3 to 9 years within a MD context.  
With the permission of the interviewees, the interviews were recorded and later 
transcribed and analysed using qualitative data analysis techniques such as open and 
axial coding as described by [25]. Other artefacts were also gathered while on site, 
such as documents describing internal processes and procedures, organisational 
charts, project metrics, corporate policies, standards, presentations, and email 
correspondence. Together with on site observations, all these artefacts were used 
within the case study to gain a more holistic view of the working environment. 
 
2.1   The Company 
 
MedTech (a pseudonym) is a large US medical device company with manufacturing 
facilities located in the United Sates and Ireland. Within the particular plant we 
investigated, the MDs do not have any embedded software, but a large effort is 
required in developing and maintaining the automation software necessary for 
manufacturing the devices. The plant performs a combination of research and 
development as well as commercial MD manufacturing. 
Like most businesses, the current global economic conditions have also taken their 
toll on MedTech. They went through a process of workforce reduction in recent years, 
and during our research we noted how this reduction has affected the way the 
employees work. As a consequence the daily endeavours of how they comply with the 
regulations, has been brought into the spotlight, something we will discuss below. 
As a committed Lean organisation, MedTech maintains quite an impressive visual 
display of their values, lean initiatives and achievements. What was interesting from 
the interviews therefore were the responses to questions probing software 
development process improvement from a lean point of view. 
 
 
3   Research Findings 
 
From our case study analysis, we show the key components which have shaped the 
development process within MedTech (Fig. 2). 
 
Fig. 2. Overview of key influences on the SDLC within MedTech 
 
Due to space limitations we expand here on just two of the important factors which 
emerged from the case study, namely: Regulations and Business Focus. These factors 
hugely influenced how the SDLC evolved to what it is today, and continue to exert 
pressure on various processes within the organisation, but particularly the product 
development process, of which the SDLC is a key sub-process. 
3.1   Regulations 
 
Ensuring that the SDLC meets the requirements of the regulations typically means 
that internal processes are defined and documented and have been mapped to a 
relevant standard. For example, an internal risk management process may be mapped 
to the international standard ISO 14971:2007 (international standard for the 
application of risk management to medical devices). However, these standards are 
open to interpretation and even with the aid of guidance documents such as those 
published by the FDA‘s CDRH (Centre for Devices and Radiological Health), and 
also due to the different classifications of MDs, it can be difficult to know exactly 
what the auditors expect. As a result there may be a tendency to overdo it in terms of 
the process, in a ‗just to be sure‘ approach. 
MedTec‘s growth was partly due to the acquisition and amalgamation of smaller 
companies. Each of these had their own internal processes, and little attention was 
given to the actual software development process. As stated during an interview: ―The 
development bit in the middle there was a bit of a black art‖. However following an 
Audit in 2005, a deficiency was found, in that they were unable to show traceability 
back to a user requirement for a particular controlling software parameter. The serious 
nature of this spurred them into a corporate initiative to revamp their processes. A 
corporate wide SDLC was defined governing all aspects of software development and 
which mapped to the relevant regulations.  
This corporate umbrella-policy was designed to cover all relevant activities: 
system upgrades, new product design, and production issue resolution. It was 
therefore necessarily high level, and consequently another level of granularity was 
required to govern at a site level. The site level SDLC process they implemented 
mapped to the corporate policy and was therefore considered to be in compliance with 
the regulations. The various teams trust that these policies are regulatory compliant. 
When asked specifically about IEC 62304 and how it affects their processes, a 
response was: ―We’ve got a regulatory group that assess standards against corporate 
policy...So I assume that activity would have happened up there‖. 
But what is evident from the case study is that, three or so years on, there is 
widespread discontent with the process. This has been acknowledged at a corporate 
level, and they have kicked off an initiative to review it. The huge amounts of 
documentation, the number and level of approvals, the time required, the cost, were 
the types of issues the interviewees had with the process. The following quote 
summarises the mood: ―You can do all this [the process] and deliver [bad quality] to 
your customer ... which is why it’s seen as a failure in the overall organisation. 
Project managers and R&D complain about it, engineering managers complain about 
it, nobody understands it, it’s just a noose, it’s just a pain really‖. 
What we have observed is that, by means of an initiative to improve the software 
development process, some very undesirable side effects have occurred. One of the 
reasons for this is that the process is indiscriminate of the focus of the activity being 
carried out. Within the R&D projects for example, the nature of the work is that they 
do not know up front exactly what it is they want the software to do. A rough idea of 
the requirements is known but many of the intricacies, for example, what margin of 
error is required, will only be known once the software and equipment have been 
prepared and trialled. So while the process calls for full requirements disclosure up 
front, followed by a lengthy change control process for any subsequent changes, this 
does not lend itself well to an iterative-type product development process typical of 
most R&D activities. Of one project, the following was said of the software process, 
―... [it would] add 4 months onto the schedule of delivering the equipment to the 
customer‖.  Such considerable overhead can make people look for short cuts, and that 
can‘t be seen as a good thing. 
 
3.2   Business Focus 
 
Breaking down the components of the business focus category we see the main 
influencers as illustrated in Fig. 3: 
 
Fig. 3. Component elements of the Business Focus factor within MedTech 
 
Again due to space restrictions, we describe two of these, Cost and Time-To-Market 
which were the highest ranked in terms of the coding process, and briefly discuss how 




Developing Medical devices is an expensive business, both in terms of the 
opportunity cost (time to market, which we present in section 4.2.2) and the cash 
burning from simply running the whole process. In a recent U.S. economic report 
[26], the premium paid to employees in the Medical Technology Industry (MTI) is 
highlighted: ―One of the outstanding characteristics of the medical technology 
industry is the strong pay scale ... almost a 40 percent premium for jobs‖.  
MedTech also went through a process of headcount reduction to reduce costs. As a 
result some process improvement initiatives have suffered by being either cancelled 
or postponed. Another effect has been that product managers are less willing to pay 
for software development unless it is really necessary. Because MedTech operate an 
internal cross-charging process, managers are less likely to proceed with software or 
equipment enhancements once they see the project estimate. Thus the effect on the 
developers is that they spend a significant amount of time producing estimates for 
software development which might never proceed. From a lean perspective this type 
of task-switching introduces waste into the process and should be minimised: ―Every 
time software developers switch between tasks, a significant switching time is 
incurred as they get their thoughts gathered and get into the flow of the new task‖ 
[17].  
MedTech also utilises contract resources on an as-needed basis which can be 
hugely expensive ―We pay contract validation resources to do all this work, to the 
scale of millions per year‖. However the duration of the software validation cycle can 
be quite difficult to estimate, and so when contract resources are employed, costs can 
very quickly accumulate. To paraphrase from one of the interviewees: if one were a 
sceptic, one might say it is in the interest of the validation contractors to find issues, 
which will add further validation needs. The problem within the MD domain is that 
validation needs to meet the requirements of the regulations, which, as the FDA 
themselves acknowledge, is difficult to define precisely [6].  
 
3.2.2 Time To Market 
 
Getting a new product through development as quickly as possible in order to move 
into the clinical trials and then commercialisation phases is becoming ever more 
critical to MD companies. Once a launch date has been set, there is very little appetite 
for delays. As one interviewee put it ―time is generally the biggest priority. Time out 
weighs cost a lot of the time here‖.  This has a consequence for the software 
development process in that there is little tolerance for changes to process that might 
introduce risk to compliance and therefore affect time to market. Following one 
particular process improvement initiative to automate a production line which led to a 
delay in time-to-market, one interviewee reported ―... the tolerance has gone to zero 
now for equipment upgrade or equipment strategy causing a delay in product time to 
market‖.  
The concentration on time to market has also created organisational inertia to 
change within the new product introduction process. This may be typical within a MD 
environment, [27] states:  ―In such a world, any significant change to culture or 
process can be difficult. Sometimes it is difficult because of the inertia inherent in a 
large organization‖. During one interview it was suggested that they could possible 
improve their manufacturing process if they spent more time researching newer 
technologies and techniques ―Time to market is the big deal here ...  It’s very rare that 
we get to develop prototype equipment, [and] test it‖. This includes the SDLC, 
because they interact with the development group and would see an iterative approach 
being more effective for them as opposed to the ‗waterfall‘ type approach which their 
process requires. What has therefore happened is they have found ways to minimise 
the process overhead, bending the rules of the process along the way. 
 
 
4.   Discussion 
 
Our investigations have brought to light some interesting effects that certain factors, 
such as regulations, have on the software development process within a MD plant. A 
possible outcome of having to adhere to regulatory requirements can be the corporate 
enforcement of a process. Speaking from the perspective of a MD firm, [27] states: 
―In our safety-critical world, we strongly believe that a robust process is an important 
element to insuring high quality. The side effect of that strong belief can be an over-
reliance on prescriptive, mandated process rules that take the approach of imposing 
discipline upon a team‖. Although it is good to have a well defined process, it seems 
that it is easy to over shoot the mark. A process which is not flexible enough to allow 
for all aspects of the business, for example the R&D section which requires an 
iterative type of process, will result in frustrated employees and possibly short cutting 
of processes. 
 
4.1   Leaning The Software Development Process 
 
It is important to have a work ethic of continuous improvement within an 
organisation. Many process improvement models such as CMMI (level 5) [28], 
ISO/IEC 15504-5 [29] refer to the highest level of process maturity having continuous 
improvement as a core element. This is similar to the lean principle of striving for 
perfection [13]. This ethos is evident within MedTech, which has been proactive in 
tackling the issues by various process improvement initiatives. For example, 
conscious of the issue of task switching when quotes are needed for potential projects, 
a process MedTech introduced that helps reduce this, is the availability of an internal 
web based tool. The tool poses a number of key questions and then gives a high level 
estimate of the project cost, ―... the number could be out by 20 or 30 % but it’s just to 
give people an order of magnitude‖. This allows managers to gauge whether or not to 
pursue the project further, thus reducing the number of non-value-add project 
estimates the developers get involved in. 
The same approach can also work with the software developers. One of the theses 
presented by [30] based on their experience of software process improvement 
initiatives is that ―Developers are motivated for change; if possible, start bottom-up 
with concrete initiatives.‖  There are various tasks the MedTech developers have 
identified that could lead to process efficiencies, such as better code re-use, code 
reviews, use of testing tools, and skills development. Many such tasks are 
independent of the regulatory environment they operate in, however what is needed is 
some form of organisational support to find time for employees to execute on these 
initiatives. Within the lean manufacturing world, this is achieved via policy 
deployment [13] pg. 95: ―The idea is for top management to agree on a few simple 
goals for transitioning [and] to designate the people and resources for getting the 
projects done‖. Some software development changes however, could be problematic 
in a MD company, for example the practice of refactoring source code [31] may cause 
unexpected results to previously completed (and possibly certified) code [32], [33]. A 
certain amount of caution is required. 
 Hiring contract staff is not an uncommon approach to manage surges in capacity, 
and with Global Software Development [34] becoming common place in many large 
companies, one could imagine that eventually it will become more common within 
the MD domain also. The case study has shown that cost considerations are less 
important than in other industries, especially when it comes to new product R&D. 
However the long project timelines typical of a new MD generate very large costs, 
something the MD industry is not immune to. In tackling the huge expense of hiring 
contract validation engineers, two lean process changes helped to reduce this cost 
exposure in MedTech. Firstly in relation to the sourcing of validation engineers: ‖... 
we’ve reduced the numbers from a contractor base and they’re not as pernickety 
now‖. Secondly, taking what can be seen as a lean approach to contract management 
[17], they changed the contract terms from time and materials to fixed price, and any 
additional work would have to be renegotiated with the requesting manager who 
would be far more reluctant to incur additional project costs: ―Now they’re very 
effective at managing scope‖. 
A big question researchers should be asking is how to apply software process 
improvement within this type of domain while keeping risk to compliance as close as 
possible to zero. Some work has been done within embedded-software domains on 
how to choose the most appropriate methodology [35] and how agile practices should 
be considered [36]. However, the only model we found relating to mission or life-
critical agile adoption [37] describes a stepped approach to deciding which agile 
practices are suitable depending on the system‘s characteristics and qualities. While 
their framework is aimed at any mission or life-critical system, it does not go into 
much detail about the various regulatory requirements. 
Within MedTech there is a great work ethos of process improvement, and within 
the software development group this is no different. There is acknowledgement that 
they could be doing things better ―Everyone using this [the process] is quite 
frustrated by how much time we spend having to document and test stuff .... And it 
costs a lot of money‖. They are actively engaged in analysing their current process in 
order to ―make [it] more effective, efficient and more lean than what we do now‖. 
This is easier said than done, and especially within the SDLC.  
Lean, having its origins in a manufacturing setting, has had limited success in 
penetrating areas such as software development. However, using the concept of lean 
software development we can see that MedTech has instigated some practices that 
have made some initial process improvements. Information hiding through 
modularisation and componentisation which remove complexity, parameterisation 
making modules less implementation specific, and code re-use are suggested lean 
practices [17].  MedTech seem to be going in the right direction having begun to build 
a library of software objects and re-usable components. As one interviewee attested 
―From the testing side I find it personally a lot better because I know that that piece 
of code, I don’t have to check it, it’s been done already and working reliably‖.  
They have also reduced waste in terms of communication between the software 
group and the more equipment focused group. Following a recent re-organisation it 
was reported that ―those two groups have merged under the one manager an there’s 
been a lot more interaction‖. Also, the developers themselves have embarked on their 
own initiative to cross-train each other so as to increase the level of expertise within 
the group ―Now we interchange rolls so those guys sometimes they do machines and 
sometimes … or whoever will do databases, screens, something like that‖. 
Further possibilities will be worth exploring for MedTech, such as establishing a 
TDD approach [20]. With their hardware dependencies, TDD, combined with the use 
of testing techniques which decouple the hardware such as bracketing-out, mocks, and 




5   Conclusion and Future Work 
 
Having examined the SDLC within a MD manufacturing plant, we identified a 
number of key influencing factors (Fig. 2) and expanded on two in this paper, namely 
regulations and business focus. While many MD companies are pre-occupied with 
achieving regulatory compliance, we have seen in this example how it can lead to a 
feeling of over doing it by applying a heavy process to all aspects of the software life-
cycle. We also identified some of the key business drivers (Fig. 3) and again 
expanded on just two of these: cost and time-to-market. The MD industry appears to 
becoming much more competitive and cost focused, and therefore companies are 
looking at ways to improve their processes but without affecting regulatory 
compliance. Since there does not seem to be a mechanism for quantifying just how 
much process is enough, it would be beneficial for a focused assessment of existing 
processes which could indicate where too much rigour is being applied and therefore 
the possibility to reduce the amount of work required. 
Lean software development, although still not very well defined, offers the 
potential for transferring the principle of lean manufacturing into software 
development and thereby achieving some of the benefits seen by lean initiatives in 
other parts of the organisation. What would be useful is a reference model of lean 
software practices which can be employed while not affecting regulatory compliance. 
The MD domain is seen as an area with huge growth potential particularly 
relevant within Ireland [40]. As an Irish based software engineering research centre, 
we therefore find it very relevant to conduct research into this domain. Indeed the 
outlook for this domain, in a global sense, is one of great advancements in technology 
leading to smaller, more complex devices merged with physiological, biological, 
engineered and physical systems. Importantly, it is anticipated that the current 
software development methodologies for such nanoscale systems will have to 
fundamentally change [41]. The challenge for the research community, therefore, is to 
develop architectures and methodologies appropriate to supporting these 
advancements while keeping an open mind as to how the regulatory bodies are likely 
to respond. Consequently, any process improvement, assessment, or reference model 
should be future proofed to allow for and support such innovations. 
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